Tricida, Inc.

Ownership Transactions Reported by 15 Insiders

Industry
Pharmaceutical Preparations
Location
7000 Shoreline Court, Suite 201, South San Francisco, CA

There are no Buy or Sell transactions made by insiders since 9/13/2023

Tricida, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
David Hirsch Director Jun 15, 2022
Klaus R. Dr Veitinger Director Jun 15, 2022
Geoffrey M. Parker COO, CFO and EVP Feb 28, 2022
David P. Bonita Director, 10%+ Owner Nov 22, 2022
Wilhelm Stahl EVP, Chief Tech Officer Dec 31, 2021
Kathryn E. Falberg Director Jun 15, 2022
Venrock Healthcare Capital Partners II, L.P. 10%+ Owner Oct 24, 2022
Robert J. Alpern Director Nov 23, 2022
Orbimed Advisors Llc Director, 10%+ Owner Nov 22, 2022
Brian M. Isern *possible member of 10% group, 10%+ Owner Oct 11, 2022
Dawn Parsell Otto EVP, Clinical Development Feb 28, 2022
Robert McKague EVP, General Counsel Feb 28, 2022
Annie Yoshiyama Senior VP, Finance and CAO Aug 5, 2022
Gerrit Klaerner President and CEO, Director Feb 28, 2022
Sandra I. Coufal Director, 10%+ Owner Jun 15, 2022

Recent Insider Transactions by Companies or Individuals for Tricida, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.